Merck Named to Corporate Responsibility Magazine’s Annual 100 Best Corporate Citizens List
Corporate Responsibility Magazine has ranked Merck #22 on its 19th annual 100 Best Corporate Citizens list. The list recognizes the standout environmental, social and governance (ESG) performance of public companies across the United States.
The 100 Best Corporate Citizens List documents 260 ESG data points of disclosure and performance measures—harvested from publicly available information in seven categories: environment, climate change, employee relations, human rights, governance, finance, and philanthropy & community support. The list ranks the Russell 1000 Index.
"CR Magazine is proud to present the only ESG ranking list that doesn't rely on self-reporting," said Dave Armon, publisher of CR Magazine. "Each year, the 100 Best Corporate Citizens ranking measures the success of the Brands Taking Stands movement by celebrating the most successful, most transparent companies that report on their responsible practices. We congratulate those honored on this year's list for their commitment to corporate responsibility."
At Merck, we aspire to being open and transparent about how we operate in order to earn and retain the trust and confidence of our customers, employees, shareholders, and other important stakeholders. We have a long history of making our medicines and vaccines accessible and affordable through responsible pricing practices and industry-leading patient access programs. Learn more: https://www.msdresponsibility.com/ethics-transparency/
See the complete 100 Best list here.
Learn more about our approach to Corporate Responsibility here.
About Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
